Skip to main content

Table 6 Univariate and Multivariable analysis of factors potentially predictive of relapse-free survival

From: High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis

Characteristics

Total(N)

Univariate analysis

Multivariate analysis

Hazard ratio (95% CI)

P value

Hazard ratio (95% CI)

P value

Age

4929

    

 <  = 60

2464

Reference

   

 > 60

2465

1.125 (0.832–2.056)

0.127

1.245(0.796–2.214)

0.414

T stage

4920

    

T1

1274

Reference

   

T2&T3&T4

3646

1.315 (1.007–2.731)

0.052

1.373 (0.826–3.134)

0.125

N stage

4894

    

N0

2143

Reference

   

N1&N2&N3

2751

2.215 (2.222–5.194)

 < 0.001

2.853 (1.321–5.317)

0.013

M stage

4801

    

M0

4637

Reference

   

M1

164

6.153 (3.064–12.612)

 < 0.001

5.132 (3.428–13.241)

 < 0.001

Pathologic stage

4887

    

Stage I

1035

Reference

   

Stage II&Stage III&Stage IV

3852

3.491 (1.613–7.423)

0.007

1.307 (0.403–3.459)

0.749

ER status

4872

    

Negative

938

Reference

   

Positive

3934

0.459 (0.313–0.725)

0.003

0.413 (0.213–0.728)

0.045

PR status

4860

    

Negative

1104

Reference

   

Positive

3756

0.617 (0.414–0.876)

0.017

0.834 (0.414–1.625)

0.407

HER2 status

4507

    

Negative

3754

Reference

   

Positive

753

1.603 (0.629–2.714)

0.315

  

radiation_therapy

4736

    

No

1975

Reference

   

Yes

2761

0.691 (0.315–1.176)

0.453

  

HSPB1

4929

    

Low

2464

Reference

   

High

2465

1.479 (1.124–1.893)

0.038

  
  1. TMN stage was according to the seventh edition of the Guidelines for the American Journal of Critical Care. ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor. Bold values indicate that p < 0.05